Range
- - -
Vol / Avg.
-/1.5M
Div / Yield
-
52 Wk
11.22 - 29.65
Mkt Cap
822.5M
Payout Ratio
-
Open
-
P/E
65.68
EPS
-0.61
Shares
50.1M
Outstanding
50.1M
Total Float
49.1M
Benzinga - Aug 23, 2021, 4:15PM
Benzinga - Aug 23, 2021, 2:52PM
load more
Sector: Health Care.Industry: Pharmaceuticals
Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-08
REV
Q2 2021Est.ActualSurprise
EPS-0.530-0.610 -0.0800
REV2.360M0-2.360M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Cara Therapeutics Questions & Anwsers

Q

How do I buy Cara Therapeutics (CARA) stock?

A

You can purchase shares of Cara Therapeutics (NASDAQ: CARA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cara Therapeutics's (CARA) competitors?

Q

What is the target price for Cara Therapeutics (CARA) stock?

A

The latest price target for Cara Therapeutics (NASDAQ: CARA) was reported by HC Wainwright & Co. on August 24, 2021. The analyst firm set a price target for 35.00 expecting CARA to rise to within 12 months (a possible 113.15% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cara Therapeutics (CARA)?

A

The stock price for Cara Therapeutics (NASDAQ: CARA) is $16.42 last updated Wed Oct 27 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Cara Therapeutics (CARA) pay a dividend?

A

There are no upcoming dividends for Cara Therapeutics.

Q

When is Cara Therapeutics (NASDAQ:CARA) reporting earnings?

A

Cara Therapeutics’s $Q3 earnings are confirmed for after-market on $November 8, 2021.

Q

Is Cara Therapeutics (CARA) going to split?

A

There is no upcoming split for Cara Therapeutics.

Q

What sector and industry does Cara Therapeutics (CARA) operate in?

A

Cara Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.